Cargando…

Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study

During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nix, Eli B., Choi, Joshua, Anthes, Christina, Gaultier, Gabrielle N., Thorgrimson, Joelle, Cox, Andrew D., Tsang, Raymond S. W., McCready, William G., Boreham, Douglas, Ulanova, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093645/
https://www.ncbi.nlm.nih.gov/pubmed/30110339
http://dx.doi.org/10.1371/journal.pone.0201282
_version_ 1783347703477960704
author Nix, Eli B.
Choi, Joshua
Anthes, Christina
Gaultier, Gabrielle N.
Thorgrimson, Joelle
Cox, Andrew D.
Tsang, Raymond S. W.
McCready, William G.
Boreham, Douglas
Ulanova, Marina
author_facet Nix, Eli B.
Choi, Joshua
Anthes, Christina
Gaultier, Gabrielle N.
Thorgrimson, Joelle
Cox, Andrew D.
Tsang, Raymond S. W.
McCready, William G.
Boreham, Douglas
Ulanova, Marina
author_sort Nix, Eli B.
collection PubMed
description During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. Conclusions: The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease.
format Online
Article
Text
id pubmed-6093645
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60936452018-08-30 Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study Nix, Eli B. Choi, Joshua Anthes, Christina Gaultier, Gabrielle N. Thorgrimson, Joelle Cox, Andrew D. Tsang, Raymond S. W. McCready, William G. Boreham, Douglas Ulanova, Marina PLoS One Research Article During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. Conclusions: The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease. Public Library of Science 2018-08-15 /pmc/articles/PMC6093645/ /pubmed/30110339 http://dx.doi.org/10.1371/journal.pone.0201282 Text en © 2018 Nix et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nix, Eli B.
Choi, Joshua
Anthes, Christina
Gaultier, Gabrielle N.
Thorgrimson, Joelle
Cox, Andrew D.
Tsang, Raymond S. W.
McCready, William G.
Boreham, Douglas
Ulanova, Marina
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
title Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
title_full Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
title_fullStr Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
title_full_unstemmed Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
title_short Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
title_sort characterization of natural bactericidal antibody against haemophilus influenzae type a in canadian first nations: a canadian immunization research network (cirn) clinical trials network (ctn) study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093645/
https://www.ncbi.nlm.nih.gov/pubmed/30110339
http://dx.doi.org/10.1371/journal.pone.0201282
work_keys_str_mv AT nixelib characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT choijoshua characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT antheschristina characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT gaultiergabriellen characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT thorgrimsonjoelle characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT coxandrewd characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT tsangraymondsw characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT mccreadywilliamg characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT borehamdouglas characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT ulanovamarina characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy